{"id":"W3197157325","doi":"10.1177/17562848211036456","title":"Characteristics of patients with moderate-to-severe ulcerative colitis treated with vedolizumab: results from a Polish multicenter, prospective, observational real-life study (the POLONEZ study)","year":2021,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Takeda Pharmaceutical Company","keywords":"Vedolizumab; Medicine; Ulcerative colitis; Internal medicine; Infliximab; Population; Concomitant; Inflammatory bowel disease; Observational study; Clinical trial; Disease","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001232107,0.0002925179,0.0003922589,0.0000517292,0.00009348896,0.00002130556,0.0002484444,0.00006031385,0.00001436632],"category_scores_gemma":[0.0000721527,0.0002161242,0.00003789872,0.0001444467,0.0001907184,0.00002609428,0.0001220178,0.0001495004,0.000001514465],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006254438,"about_ca_system_score_gemma":0.0001389112,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008546499,"about_ca_topic_score_gemma":0.005585084,"domain_scores_codex":[0.9976081,0.0006095894,0.0005117675,0.0006353148,0.0002639006,0.0003713797],"domain_scores_gemma":[0.998482,0.00005153686,0.0003004197,0.0005462971,0.0005176457,0.0001020248],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.09060428,0.002255918,0.9044985,0.000006779162,0.0003833747,0.00007719253,0.00123011,0.0006373424,0.0001156062,0.00001283033,0.000003607945,0.0001745047],"study_design_scores_gemma":[0.01531753,0.003786975,0.9790037,0.00002277041,0.0001021643,0.000002198771,0.001353794,0.00006777493,0.0001430871,0.00001804461,0.00002985701,0.0001520598],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971969,0.00002113286,0.0002674297,0.00007175697,0.0000643008,0.001591809,0.0007344373,0.00001239387,0.00003985784],"genre_scores_gemma":[0.9983208,0.00003372373,0.0002171254,0.0004959733,0.00006353869,0.0002532937,0.0005481881,0.00003628308,0.00003104622],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07528675,"threshold_uncertainty_score":0.8813289,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01282159644689429,"score_gpt":0.2616732062089895,"score_spread":0.2488516097620952,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}